MCK vs CAH vs GRDN Stock Comparison

Mckesson, Cardinal Health and Guardian Pharmacy Services Prices as of Nov 13, 2026 Peers: Industry group
MCK Mckesson Corp
$1,102.82 +12.7% 1M +30.3% 1Y
Market cap
$127.33B
P/E
27.3x
Revenue (TTM)
$418.79B
Div. yield
0.31%
Drug Distribution Healthcare
5 wins
CAH Cardinal Health Inc
$281.08 +13.4% 1M +36.4% 1Y
Market cap
$64.97B
P/E
35.9x
Revenue (TTM)
$257.75B
Div. yield
0.73%
Drug Distribution Healthcare
4 wins

Head to Head

12 decided of 12

Mckesson leads on 5 of the 12 questions below (Mckesson 5, Cardinal Health 4, Guardian Pharmacy Services 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMCKCAHGRDNLeader
Larger companyMarket capitalisation $127.33B $64.97B $3.13B MCK
Cheaper on earningsLower P/E, profitable companies only 27.3x 35.9x 41.9x MCK
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.8x 22.8x 37.5x MCK
Faster revenue growthRevenue growth, trailing twelve months +8.2% +10.0% +4.9% CAH
More profitableNet margin, trailing twelve months 1.1% 0.7% 5.1% GRDN
Better return on capitalReturn on invested capital 98.7% 36.5% — MCK
Less leveragedLower net debt / EBITDA 0.4x 1.0x — MCK
Higher dividend yieldTrailing dividend yield 0.31% 0.73% — CAH
Better 1-year returnPrice return, last 12 months +30.3% +36.4% +62.6% GRDN
Better 5-year returnAnnualised price return, 5 years +37.5%/yr +40.5%/yr — CAH
Less volatileAnnualised volatility, 1 year 31.4% 25.9% 42.4% CAH
Higher overall scoreMean of the five percentile scores vs peers 58/100 60/100 71/100 GRDN

Percentile Scorecard

MCKCAHGRDN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMCKCAHGRDN
Valuation 65 #10 of 27 77 #7 of 27 23 #21 of 27
Growth 56 #12 of 26 68 #9 of 26 76 #7 of 26
Profitability 56 #12 of 26 60 #11 of 26 96 #2 of 26
Financial Health 56 #12 of 26 40 #16 of 26 88 #4 of 26
Shareholder Returns 59 #8 of 18 53 #9 of 18 –
Overall 58 60 71
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • CAH ranked among 27 companies in Healthcare Payers and Distributors
  • GRDN ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMCKCAHGRDNSPY
1 month +12.7%+13.4%+21.9% -2.0%
3 months +26.9%+19.5%+28.7% -2.8%
6 months +45.0%+44.0%+35.1% +2.0%
Year to date +34.4%+36.8%+64.4% +10.6%
1 year +30.3%+36.4%+62.6% +12.2%
3 years +143.0%+173.2%— +68.1%
3 years, per year +34.5%+39.8%— +18.9%
5 years +390.5%+446.4%— +61.4%
5 years, per year +37.5%+40.5%— +10.1%
10 years +671.0%+293.8%— +248.5%
10 years, per year +22.7%+14.7%— +13.3%

Risk

MeasureMCKCAHGRDNSPY
Volatility, 1Y 31.4%25.9%42.4% 13.6%
Downside volatility, 1Y 27.2%24.8%39.1% 13.9%
Beta vs S&P 500, 1Y -0.18-0.010.71 1.00
Return / volatility, 1Y 0.971.411.48 0.90
Max drawdown, 5Y -27.2%-21.0%-27.2% -25.4%
From 52-week high 0.0%0.0%-1.1% -3.2%
52-week high $1,102.82$281.08$50.01 $779.14
52-week low $725.17$182.50$27.03 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMCKCAHGRDN
P/E now vs peer median 27.3xmedian 25.2x 35.9xmedian 25.2x 41.9xmedian 25.2x
P/S now vs peer median 0.3xmedian 0.4x 0.3xmedian 0.4x 2.2xmedian 0.4x
EV/EBITDA now vs peer median 17.4xmedian 14.5x 18.7xmedian 14.5x 25.6xmedian 14.5x
P/FCF now vs peer median 17.9xmedian 16.5x 13.3xmedian 16.5x 40.0xmedian 16.5x
P/B now vs peer median -32.2xmedian 2.7x -21.5xmedian 2.7x 11.2xmedian 2.7x
PEG now vs peer median 1.72median 1.72 0.40median 1.72 —median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMCKCAHGRDN
Revenue $418.79B $257.75B $1.46B
Gross profit $15.37B $10.05B $327.08M
Operating income $6.69B $2.70B $94.14M
Net income $5.43B $1.82B $74.77M
Free cash flow $7.11B $4.90B $78.35M
EPS (diluted) $40.27 $7.80 $1.17
Cash & equivalents $6.53B $5.26B $119.66M
Total debt $9.21B $8.82B –
Shares (diluted) 116.70M 233.00M 63.92M
Enterprise value $111.26B $48.29B $2.81B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMCKCAHGRDN
P/E 27.3x 35.9x 41.9x
P/FCF 17.9x 13.3x 40.0x
P/Operating cash flow 17.0x 11.6x 27.5x
P/S 0.3x 0.3x 2.2x
P/B -32.2x -21.5x 11.2x
P/Tangible book -16.1x -21.5x 12.1x
EV/EBITDA 17.4x 18.7x 25.6x
EV/EBIT 19.4x 25.4x 32.0x
EV/Revenue 0.3x 0.3x 2.1x
EV/FCF 18.3x 14.0x 38.5x
EV/Operating cash flow 17.3x 12.2x 26.4x
PEG (3Y EPS CAGR) 1.72 0.40 –

Growth

14 metrics
MetricMCKCAHGRDN
Revenue growth (1Y) 8.2% 10.0% 4.9%
Revenue CAGR (3Y) 12.9% 7.1% –
Gross profit growth (1Y) 11.8% 17.1% 19.2%
Gross profit CAGR (3Y) 7.6% 12.6% –
Operating income growth (1Y) 27.3% 13.6% 60.4%
Operating income CAGR (3Y) 16.1% 63.6% –
Net income growth (1Y) 28.5% 13.6% 85.8%
Net income CAGR (3Y) 14.2% 86.5% –
EPS growth (1Y) 24.2% 16.9% 84.4%
EPS CAGR (3Y) 15.9% 90.8% –
Operating cash flow growth (1Y) 9.3% 11.6% 29.6%
Operating cash flow CAGR (3Y) 15.2% 18.7% –
Free cash flow growth (1Y) 11.8% 10.1% 18.9%
Free cash flow CAGR (3Y) 16.3% 19.9% –

Profitability

14 metrics
MetricMCKCAHGRDN
Gross margin 3.7% 3.9% 22.4%
EBITDA margin 1.8% 1.4% 8.1%
Operating margin 1.6% 1.0% 6.5%
Pretax margin 1.6% 0.9% 7.2%
Net margin 1.1% 0.7% 5.1%
FCF margin 1.7% 1.9% 5.4%
Operating cash flow margin 1.8% 2.2% 7.8%
Return on equity – – 28.3%
Return on assets 6.0% 3.1% 16.3%
Return on invested capital 98.7% 36.5% –
Return on capital employed 42.0% 22.3% 32.6%
Asset turnover 4.6x 4.4x 3.1x
Cash conversion (OCF / net income) 1.4x 3.1x 1.5x
Stock comp / revenue – 0.1% 0.6%

Financial Health

11 metrics
MetricMCKCAHGRDN
Debt / assets 10.0% 14.8% –
Debt / equity -2.3x -2.9x –
Net debt / EBITDA 0.4x 1.0x –
Debt / FCF 1.3x 1.8x –
Liabilities / assets 104.3% 105.1% 43.1%
Equity / assets -4.3% -5.1% 56.9%
Interest coverage 21.9x 7.9x 145.3x
Current ratio 0.9x 0.9x 1.6x
Quick ratio 0.5x 0.4x 1.3x
Cash ratio 0.1x 0.1x 0.7x
Altman Z-score 5.83 5.05 13.09

Shareholder Returns

7 metrics
MetricMCKCAHGRDN
Dividend yield 0.3% 0.7% –
Net buyback yield 5.2% 2.3% –
Shareholder yield 5.6% 3.0% –
Payout ratio (earnings) 7.4% 26.8% –
Payout ratio (FCF) 5.6% 10.0% –
Dividend growth (1Y) 10.5% -1.4% –
Dividend CAGR (3Y) 9.8% -1.7% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMCKCAHGRDN
Forward P/E 22.8xFY2026 22.8xFY2027 37.5xFY2026
EPS, next fiscal year $48.34FY2026 $12.31FY2027 $1.32FY2026
EPS growth, next FY +23.6%FY2026 +9.3%FY2027 +23.4%FY2026
EPS growth, the year after +11.9% +12.8% +18.9%
Revenue, next fiscal year $447.65BFY2026 $273.40BFY2027 $1.42BFY2026
Revenue growth, next FY +11.0%FY2026 +7.5%FY2027 -2.2%FY2026
Revenue growth, the year after +1.5% -3.5% +2.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMCKCAHGRDN
Held by institutions 89.1% 87.4% 58.6%
Institutions holding 2,014 1,494 189
Change in shares held, QoQ -0.7% +2.8% +3.8%
Institutions buying 883 711 109
Institutions selling 793 559 54
Buyers to sellers 1.11 1.27 2.02

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MCKCAHGRDN
MCK 1.00 0.73 0.18
CAH 0.73 1.00 0.15
GRDN 0.18 0.15 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MCK, CAH and GRDN?

Mckesson (MCK) is the largest by market capitalisation: Mckesson (MCK) $127.33B, Cardinal Health (CAH) $64.97B, Guardian Pharmacy Services (GRDN) $3.13B.

Which stock is cheaper, MCK, CAH and GRDN?

Mckesson (MCK) trades on the lowest price-to-earnings ratio (Mckesson (MCK) 27.3x, Cardinal Health (CAH) 35.9x, Guardian Pharmacy Services (GRDN) 41.9x). On next year's consensus earnings, Mckesson (MCK) is cheapest (Mckesson (MCK) 22.8x, Cardinal Health (CAH) 22.8x, Guardian Pharmacy Services (GRDN) 37.5x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Cardinal Health (CAH) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.2%, Cardinal Health (CAH) +10.0%, Guardian Pharmacy Services (GRDN) +4.9%.

Which company is more profitable?

Guardian Pharmacy Services (GRDN) has the highest net margin (Mckesson (MCK) 1.1%, Cardinal Health (CAH) 0.7%, Guardian Pharmacy Services (GRDN) 5.1%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 98.7%, Cardinal Health (CAH) 36.5%).

Which stock has performed better?

Over the past year Guardian Pharmacy Services (GRDN) returned the most: Mckesson (MCK) +30.3%, Cardinal Health (CAH) +36.4%, Guardian Pharmacy Services (GRDN) +62.6%. Over five years, Cardinal Health (CAH) compounded fastest (Mckesson (MCK) +37.5%/yr, Cardinal Health (CAH) +40.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Cardinal Health (CAH) has the highest dividend yield: Mckesson (MCK) 0.31%, Cardinal Health (CAH) 0.73%. Guardian Pharmacy Services (GRDN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cardinal Health (CAH) has been the steadiest (Mckesson (MCK) 31.4%, Cardinal Health (CAH) 25.9%, Guardian Pharmacy Services (GRDN) 42.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MCK, CAH and GRDN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.